SCIENTIFIC BACKGROUND

HLA-DQA1, HLA-DQB1

Category:

Celiac disease, also known as endemic sprue in adults, is an autoimmune disease caused by cereal protein that manifests itself in the small intestine. This results in lymphocytic infiltration and damage to the intestinal mucosa. The activation of B-lymphocytes leads to the formation of various celiac disease specific antibodies, which can be determined if celiac disease is suspected.

 

Celiac disease is one of the diseases most strongly associated with human leukocyte antigen (HLA). Nearly all celiac patients carry the HLA class II markers HLA-DQ2 and/or HLA-DQ8 and only these HLA molecules are able to present gliadin peptides (breakdown products of gluten) and trigger an immunological reaction. About 95% of patients are positive for HLA-DQ2 (DQB1*02, DQA1*05). Most of the remaining patients are carriers of HLA-DQ8 (DQB1*03:02, DQA1*03). The negative predictive value of the HLA determination is thus close to 100%. The positive predictive value, on the other hand, is very low, since about 40% of the European population possess these HLA characteristics. The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines recommend the determination of HLA-DQ2 and -DQ8 in patients with an uncertain diagnosis due to unclear biopsy or antibody findings. HLA determination can be used to confirm disease in children with a strong clinical suspicion of celiac disease and high antibody titers if a small intestine biopsy is not performed. In asymptomatic persons with an increased risk of celiac disease, an HLA determination should be performed. If no HLA-DQ2 / DQ8 characteristics are detected, regular serological monitoring is not necessary.

 

References

Husby et al. 2012, JPGN 54:136 / Di Sabatino et al. 2009, Lancet 373:1480 / HLA in Health and Disease second ed. R. Lechler, A. Warrens Academic Press, London, 2000 / Sollid et al. 1989, J Exp Med 169:345 / Y.Ghodke et al. 2005, Eur J of Epid 20:475-488 / HLA and Disease Associations, J. L. Tiwari, P. I. Terasaki Springer-Verlag, New York, 1985

GENES

HLA-DQA1, HLA-DQB1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more